Global Structural Heart Devices Market Forecast up to 2024

  • 97

  • 25

  • 42

  • 4 / 0
    Regions/ Countries

  • 10

  • 10
    Enquiry Hours


Structural Heart Disease are the abnormalities in the heart by birth or which develop later in life because of aging, infections, or injury, which leads to heart attacks and other underlying ailments. The term structural heart disease involves a range of ailments linked with congestive heart failure (CHF) and embolic stroke, together with atrial septal defect (ASD), ventricular septal defect (VSD), patent foramen ovale (PFO) and left atrial appendix (LAA).

Increasing aging population, increasing prevalence of cardiovascular diseases, and increase in minimally invasive surgery for structural heart diseases are the factors aiding for the growth of the structural heart devices market. Increase healthcare spending, increase in the number of outpatient procedures, and market expansion opportunities in emerging nations are providing an opportunity for the market growth. However, lack of skilled healthcare professionals and stringent regulatory approval process are hampering the market growth.

Market Analysis – The “Global Structural Heart Devices Market” is estimated to witness a CAGR of 10.2% during the forecast period 2018–2024. The structural heart devices market is analyzed based on three segments – Type, End Users, and Regions.

Regional Analysis – The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). North America accounts for the largest share of the structural heart devices market, followed by Europe, Asia Pacific, and Rest of the World. More than 40% of the market is occupied by North America, with the US being the major contributor to the market growth in 2017.

Type Analysis – Based on the type, the market is segmented into structural heart repair devices and structural heart replacement devices. The major share holder of the market are structural heart replacement devices and is also the fastest growing segment in the market.

End Users Analysis – Based on the end users, the market is segmented into hospitals, ambulatory surgical centers, and cardiac centers. The hospitals are the largest among end-users and are preferred for the treatment due to the advantages such as availability of surgery specialists, reimbursement facility, and availability of high end equipment for the surgery.

Key Players – The major players in the market are Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Edward LifeSciences Corp., and LivaNova PLC. Lepu Medical Technology, CryoLife, Inc., JenaValve Technologies GmbH, TTK Healthcare, and Braile Biomédica, are the key other key players in the market.

Competitive Analysis – Mergers and acquisitions has been the major strategy followed by major players in the market to maintain their leadership in the market. Edwards congealed its position in the mitral valve market by buying the Harpoon Medical, the DMR-focused chordal surgical mitral valve repair startup company for ~$100M upfront. Many players in the market are flooding into the TMVR arena, the market can expect strong and innovative state-of-the-art technologies, creating intense competition in the future. A Canadian company, NeoVasc has developed a novel technology device named Tiara to replace any regurgitation of mitral valves. However, these devices have not gained approval yet and as such are lagging far behind the MitraClip. As a result, Abbott Vascular will have many years to solidify its place as the market leader in TMVR solutions.

Benefits – The report provides complete details about the usage and adoption rate of structural heart devices in various regions. With that, key stakeholders can know about the major trends, drivers, investments, and vertical player’s initiatives. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.

Key Stakeholders

1     Industry Outlook 

1.1        Industry Overview

1.2        Total Addressable Market

2     Report Outline 

2.1        Report Scope

2.2        Report Summary

2.3        Research Methodology

2.4        Report Assumptions

3     Market Snapshot

3.1        Market Definition – Infoholic Research

3.2        Segmented Addressable Market (SAM)

3.2.1     Symptoms of Structural Heart Disease

3.3        Industry Trends

3.4        Related Markets

3.4.1     Cardiovascular Drugs    Trends of the Cardiovascular Drugs Market

3.4.2     Cardiovascular Diagnostics

3.4.3     Prosthetic Heart Valves

4     Market Outlook 

4.1        Reimbursement

4.2        Porter 5 (Five) Forces

5     Market Characteristics

5.1        Evolution

5.2        Market Segmentation

5.3        Market Dynamics

5.3.1     Drivers    Increase in Minimally Invasive Surgery for Structural Heart Diseases    Increasing prevalence of cardiovascular diseases    Increasing Aging Population

5.3.2     Restraints    Stringent Regulatory Approval Process    Lack of skilled healthcare professionals

5.3.3     Opportunities    Increase in healthcare spending    Increase in the number of outpatient procedures    Market expansion opportunities in emerging nations

5.3.4     DRO – Impact Analysis

5.4        Key Stakeholders

6     Types – Market Size and Analysis

6.1        Overview

6.2        Structural Heart Repair Devices

6.2.1     Surgical Heart Repair Devices

6.2.2     Transcatheter Heart Repair Devices

6.3        Structural Heart Replacement Devices

6.3.1     Surgical Heart Replacement Devices

6.3.2     Transcatheter Heart Replacement Devices

7     End Users – Market Size and Analysis

7.1        Overview

7.2        Hospitals

7.3        Ambulatory Surgical Center

7.4        Cardiac Centers

8     Regions – Market Size and Analysis

8.1        Overview

8.2        North America

8.2.1     Overview

8.3        Europe

8.3.1     Overview

8.4        Asia Pacific

8.4.1     Overview

8.5        Rest of the World

8.5.1     Overview

9     Competitive Landscape 

10   Vendors Profile 

10.1     Abbott Laboratories

10.1.1  Overview

10.1.2  Business Units

10.1.3  Geographic Presence

10.1.4  Business Focus

10.1.5  SWOT Analysis

10.1.6  Business Strategies

10.2     Boston Scientific Corp.

10.2.1  Overview

10.2.2  Business Units

10.2.3  Geographic Presence

10.2.4  Business Focus

10.2.5  SWOT Analysis

10.2.6  Business Strategies

10.3     Medtronic Plc

10.3.1  Overview

10.3.2  Business Units

10.3.3  Geographic Presence

10.3.4  Business Focus

10.3.5  SWOT Analysis

10.3.6  Business Strategies

10.4     Edwards Lifesciences Corp

10.4.1  Overview

10.4.2  Business Units

10.4.3  Geographic Presence

10.4.4  Business Focus

10.4.5  SWOT Analysis

10.4.6  Business Strategies

10.5     LivaNova PLC

10.5.1  Overview

10.5.2  Business Units

10.5.3  Geographic Presence

10.5.4  Business Focus

10.5.5  SWOT Analysis

10.5.6  Business Strategies

11   Companies to Watch for

11.1     Lepu Medical Technology Co., Ltd.

11.1.1  Overview

11.1.2  Key Highlights

11.2     CryoLife, Inc

11.2.1  Overview

11.2.2  Key Highlights

11.3     JenaValve Technology GmbH

11.3.1  Overview

11.3.2  Key Highlights

11.4     TTK Healthcare Ltd.

11.4.1  Overview

11.4.2  Key Highlights

11.5     Braile Biomédica

11.5.1  Overview


Ø            Acronyms

Infoholic research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:

  • Data Collation (Primary & Secondary)
  • In-house Estimation (Based on proprietary data bases and Models)
  • Market Triangulation
  • Forecasting

infoholic Research Methodology

Market related information is congregated from both primary and secondary sources.

Primary sources involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.

Secondary sources include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.